Delving into the Latest Updates on Serentis Ltd. with Synapse

概览

关联

4

项与 Serentis Ltd. 相关的临床试验

NCT00882245 / Completed临床2期

A Phase II, Double-Blind, Vehicle Controlled Study to Determine the Efficacy, Safety and Toleration of SRD441 Ointment in Patients With Atopic Dermatitis

Atopic Dermatitis is a chronic inflammatory skin disease that affect 10 to 15% of children and 2 to 10% of adults. AD is characterised by an itchy skin eruption and may cover large parts of the body. The exact cause is unknown but is thought to be an interplay between genetic and and environmental factors. The objective of this study is to determine whether SRD441 ointment is a safe and effective therapy for mild to moderate Atopic Dermatitis.

开始日期2009-04-01

申办/合作机构

Serentis Ltd.

EUCTR2008-007323-64-BG / Not yet recruitingN/A

A phase II, double-blind, vehicle controlled study to determine the efficacy, safety and toleration of SRD441 ointment in patients with atopic dermatitis -

开始日期2009-02-19

申办/合作机构

Serentis Ltd.

EUCTR2008-007323-64-DE / Not yet recruitingN/A

A phase II, double-blind, vehicle controlled study to determine the efficacy, safety and toleration of SRD441 ointment in patients with atopic dermatitis -

开始日期2009-02-09

申办/合作机构

Serentis Ltd.

100 项与 Serentis Ltd. 相关的临床结果

登录后查看更多信息

0 项与 Serentis Ltd. 相关的专利（医药）

登录后查看更多信息

100 项与 Serentis Ltd. 相关的药物交易

登录后查看更多信息

100 项与 Serentis Ltd. 相关的转化医学

登录后查看更多信息

组织架构

使用我们的机构树数据加速您的研究。

登录

或

查看完整样例数据

管线布局

2024年12月07日管线快照

管线布局中药物为当前组织机构及其子机构作为药物机构进行统计，早期临床1期并入临床1期，临床1/2期并入临床2期，临床2/3期并入临床3期

其他

7

登录后查看更多信息

当前项目

药物(靶点)	适应症	全球最高研发状态

SRD-326	雷诺病更多	终止
SRD-285	创伤和损伤更多	终止
SRD-441 ( MMPs x 金葡球菌金属蛋白酶 )	特应性皮炎更多	无进展
SRD-803	粘膜炎更多	无进展
STP-01b ( Protease )	特应性皮炎更多	无进展